|
| 诚达药业(301201)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-07-21 | 6155.94 | 39.79% | 15471.38 | 0.00 | 8719.38 | 56.36% | 追加承诺限售股份上市流通 | | 2025-01-20 | 596.06 | 3.85% | 9315.45 | 6155.94 | 8719.38 | 56.36% | 首发原股东限售股份 | | 2023-11-17 | 320.00 | 2.07% | 8719.38 | 6752.00 | 8399.38 | 54.29% | 首发原股东限售股份 | | 2023-02-16 | 90.80 | 0.94% | 5249.61 | 4420.00 | 5249.61 | 54.29% | 首发战略配售股份 | | 2023-01-20 | 2832.21 | 29.29% | 5202.53 | 4467.09 | 5202.53 | 53.80% | 首发原股东限售股份 | | 2022-07-20 | 124.74 | 1.29% | 2391.86 | 7277.76 | 2391.86 | 24.74% | 首发机构配售股份 | | 2022-01-20 | 2201.87 | 22.77% | 2201.87 | 7467.75 | 2201.87 | 22.77% | 首发一般股份 |
|